Kynam Capital Management

Kynam Capital Management as of March 31, 2022

Portfolio Holdings for Kynam Capital Management

Kynam Capital Management holds 33 positions in its portfolio as reported in the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Global Blood Therapeutics In 15.0 $46M 1.3M 34.64
Natera (NTRA) 12.8 $39M 966k 40.68
Syndax Pharmaceuticals (SNDX) 10.9 $34M 1.9M 17.38
Celldex Therapeutics Com New (CLDX) 8.3 $26M 753k 34.06
Travere Therapeutics (TVTX) 7.3 $22M 871k 25.77
Gossamer Bio (GOSS) 5.2 $16M 1.8M 8.68
Xenon Pharmaceuticals (XENE) 4.8 $15M 483k 30.57
Vaxcyte (PCVX) 4.5 $14M 580k 24.15
Vera Therapeutics Cl A (VERA) 3.8 $12M 502k 23.49
Miragen Therapeutics (VRDN) 3.5 $11M 590k 18.49
Liquidia Corporation Com New (LQDA) 2.7 $8.3M 1.2M 7.18
Biogen Idec (BIIB) 2.6 $8.1M 38k 210.61
Amarin Corp Spons Adr New (AMRN) 2.4 $7.5M 2.3M 3.29
Burning Rock Biotech Sponsored Ads (BNR) 2.3 $7.2M 773k 9.29
Sierra Oncology Com New 2.0 $6.2M 193k 32.05
Centessa Pharmaceuticals Sponsored Ads (CNTA) 1.9 $6.0M 669k 8.97
Amicus Therapeutics (FOLD) 1.8 $5.4M 574k 9.47
Wave Life Sciences SHS (WVE) 1.2 $3.8M 1.9M 2.00
Fate Therapeutics (FATE) 1.1 $3.5M 91k 38.77
Merus N V (MRUS) 1.0 $3.1M 117k 26.44
Seres Therapeutics (MCRB) 0.7 $2.1M 291k 7.12
Puma Biotechnology (PBYI) 0.6 $1.9M 653k 2.88
Akouos 0.6 $1.8M 388k 4.75
Radius Health Com New 0.5 $1.6M 186k 8.83
Affimed Therapeutics B V 0.5 $1.5M 348k 4.37
Cabaletta Bio (CABA) 0.4 $1.3M 616k 2.03
Krystal Biotech (KRYS) 0.4 $1.2M 18k 66.55
Olema Pharmaceuticals (OLMA) 0.4 $1.2M 281k 4.26
Connect Biopharma Hldgs Ads (CNTB) 0.2 $688k 228k 3.02
Tg Therapeutics Put Option (TGTX) 0.1 $401k 259k 1.55
Neoleukin Therapeutics 0.1 $264k 141k 1.88
Nektar Therapeutics Put Option (NKTR) 0.1 $260k 200k 1.30
Catalyst Biosciences Com New 0.0 $70k 106k 0.66